首页 > 最新文献

Movement Disorders最新文献

英文 中文
Movement Disorders Thanks Journal Reviewers from 2025 感谢2025年的期刊审稿人。
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-16 DOI: 10.1002/mds.70203
A. Jon Stoessl MD
{"title":"Movement Disorders Thanks Journal Reviewers from 2025","authors":"A. Jon Stoessl MD","doi":"10.1002/mds.70203","DOIUrl":"10.1002/mds.70203","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"41 1","pages":"8-15"},"PeriodicalIF":7.6,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Autonomic Burden in Prodromal Parkinson's Disease Predicts Cognitive Impairment. 前驱帕金森病的早期自主神经负担预示认知障碍。
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-14 DOI: 10.1002/mds.70202
A Enrique Martinez-Nunez,Kelly A Mills,Joseph Seemiller,Christopher B Morrow,Gregory M Pontone,Abhimanyu Mahajan
BACKGROUNDAutonomic dysfunction is a known contributor to cognitive impairment in Parkinson's disease (PD), but its impact during prodromal stage is unknown.OBJECTIVEThe aim was to determine whether early autonomic burden predicts incident cognitive impairment in prodromal PD.METHODSWe analyzed data from Parkinson's Progression Markers Initiative participants. Autonomic dysfunction was defined as Scales for Outcomes in Parkinson's Disease Autonomic Dysfunction score ≥13, documented prior to phenoconversion. Cox regression assessed the predictors of cognitive impairment, and mixed-effects analysis of variance compared domain-specific cognitive trajectories.RESULTSData on 382 participants were analyzed. Early autonomic dysfunction was significantly associated with increased risk of mild cognitive impairment or dementia (P < 0.001), especially in semantic fluency and letter-number sequencing. Cardiovascular autonomic burden, specifically, was a strong independent predictor (HR = 5.21, P = 0.01).CONCLUSIONSAutonomic dysfunction in prodromal PD is a risk factor for cognitive decline, providing opportunity for early risk stratification and intervention. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
背景:自主神经功能障碍是帕金森病(PD)认知障碍的一个已知因素,但其在前驱期的影响尚不清楚。目的探讨早期自主神经负担是否能预测PD前驱期认知功能障碍的发生。方法:我们分析了帕金森进展标志物计划参与者的数据。自主神经功能障碍定义为帕金森病自主神经功能障碍评分≥13分,在表型转化前记录。Cox回归评估了认知障碍的预测因素,混合效应方差分析比较了特定领域的认知轨迹。结果对382名参与者的数据进行了分析。早期自主神经功能障碍与轻度认知障碍或痴呆的风险增加显著相关(P < 0.001),尤其是在语义流畅性和字母数字排序方面。特别是心血管自主神经负担是一个强有力的独立预测因子(HR = 5.21, P = 0.01)。结论PD前驱期自主神经功能障碍是认知能力下降的危险因素,为早期风险分层和干预提供了机会。©2026作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
{"title":"Early Autonomic Burden in Prodromal Parkinson's Disease Predicts Cognitive Impairment.","authors":"A Enrique Martinez-Nunez,Kelly A Mills,Joseph Seemiller,Christopher B Morrow,Gregory M Pontone,Abhimanyu Mahajan","doi":"10.1002/mds.70202","DOIUrl":"https://doi.org/10.1002/mds.70202","url":null,"abstract":"BACKGROUNDAutonomic dysfunction is a known contributor to cognitive impairment in Parkinson's disease (PD), but its impact during prodromal stage is unknown.OBJECTIVEThe aim was to determine whether early autonomic burden predicts incident cognitive impairment in prodromal PD.METHODSWe analyzed data from Parkinson's Progression Markers Initiative participants. Autonomic dysfunction was defined as Scales for Outcomes in Parkinson's Disease Autonomic Dysfunction score ≥13, documented prior to phenoconversion. Cox regression assessed the predictors of cognitive impairment, and mixed-effects analysis of variance compared domain-specific cognitive trajectories.RESULTSData on 382 participants were analyzed. Early autonomic dysfunction was significantly associated with increased risk of mild cognitive impairment or dementia (P < 0.001), especially in semantic fluency and letter-number sequencing. Cardiovascular autonomic burden, specifically, was a strong independent predictor (HR = 5.21, P = 0.01).CONCLUSIONSAutonomic dysfunction in prodromal PD is a risk factor for cognitive decline, providing opportunity for early risk stratification and intervention. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"36 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta-Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. 帕金森病新的和慢性丘脑下核深部脑刺激的β -带和非周期活动。
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-14 DOI: 10.1002/mds.70198
Arjun Balachandar,Alexandra Boogers,Sara Naghdlou,Andres M Lozano,Suneil K Kalia,Gerd Tinkhauser,Alfonso Fasano
BACKGROUNDNeurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long-term utility is not clear, especially when transitioning to sensing-guided DBS years post-surgery.OBJECTIVESBeta-band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale-Part III (MDS-UPDRS-III).RESULTSBeta-band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power.CONCLUSIONSSTN beta-band-related biomarkers inform disease state of de novo and chronic PD-DBS cohorts, with signal properties relevant for sensing-guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
帕金森氏病(PD)的神经生理生物标志物越来越多地用于深部脑刺激(DBS)。它们的长期效用尚不清楚,特别是在术后数年过渡到感觉引导的DBS时。目的:比较新植入和长期植入PD患者(6.7±4.0年)丘脑下核DBS电极记录的β带功率、爆发活动和局部场电位的周期性和非周期性成分。临床严重程度采用运动障碍学会统一帕金森病评定量表第三部分(MDS-UPDRS-III)评定。结果慢性植入组的β波段功率和爆发幅度显著高于慢性植入组,非周期偏移和指数显著低于慢性植入组。周期峰值频率和功率无显著差异。临床严重程度与累积爆发时间和爆发率相关。纵向子集显示峰值频率或功率没有变化。结论:sstn β -波段相关生物标志物可告知PD-DBS新生患者和慢性PD-DBS患者的疾病状态,其信号特性与感知引导的DBS相关。©2026作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
{"title":"Beta-Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.","authors":"Arjun Balachandar,Alexandra Boogers,Sara Naghdlou,Andres M Lozano,Suneil K Kalia,Gerd Tinkhauser,Alfonso Fasano","doi":"10.1002/mds.70198","DOIUrl":"https://doi.org/10.1002/mds.70198","url":null,"abstract":"BACKGROUNDNeurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long-term utility is not clear, especially when transitioning to sensing-guided DBS years post-surgery.OBJECTIVESBeta-band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale-Part III (MDS-UPDRS-III).RESULTSBeta-band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power.CONCLUSIONSSTN beta-band-related biomarkers inform disease state of de novo and chronic PD-DBS cohorts, with signal properties relevant for sensing-guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"29 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intake of Folate, Vitamin B6, and Vitamin B12 Before and After Disease Diagnosis and the Risk of Death in Individuals with Parkinson's Disease. 帕金森病患者疾病诊断前后叶酸、维生素B6和维生素B12的摄入量与死亡风险
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-12 DOI: 10.1002/mds.70178
Xinyuan Zhang,Mario H Flores-Torres,Chadwick W Christine,Kjetil Bjornevik,Albert Y Hung,Michael A Schwarzschild,Alberto Ascherio
Objective The aim of this study was to examine whether the intake of folate, vitamin B6, and vitamin B12 before and after disease diagnosis impacts the risk of death among individuals with Parkinson's disease (PD). The impact of folate, vitamin B6, and B12 intake on mortality in individuals with PD is unknown. Methods The study population comprised 1521 participants of two large prospective cohorts who were newly diagnosed with PD during follow-up. Participants responded to repeated dietary assessments using validated food frequency questionnaires, covering up to 30 years before to more than 10 years after PD diagnosis. We estimated the hazard ratio (HR) and 95% confidence interval (CI) of death according to quartiles of the cumulative average intake of B vitamins before and after disease diagnosis. We also examined PD-specific mortality and alternative exposure definitions. Results We documented 1005 deaths during 15 years of follow-up. A higher cumulative average intake of B vitamins before disease diagnosis was associated with a lower risk of death among patients with PD. The multivariable-adjusted HR (95% CI) of death comparing top to bottom quartiles of intakes was 0.78 (0.62-0.99) for folate, 0.76 (0.62-0.93) for B6, and 0.86 (0.69-1.09) for B12. These estimates were stronger in analyses restricting to intakes from supplemental sources and in those considering intakes reported up to 12 years before diagnosis. The intake of these B vitamins after PD diagnosis was not associated with the risk of death. Conclusions Higher intake of B vitamins before disease diagnosis, particularly folate and vitamin B6, may decrease the risk of death in individuals with PD. Postdiagnosis intake did not appear to impact survival.
目的探讨帕金森病(PD)患者诊断前后叶酸、维生素B6和维生素B12的摄入是否影响其死亡风险。叶酸、维生素B6和B12摄入对PD患者死亡率的影响尚不清楚。方法研究人群包括两个大前瞻性队列的1521名参与者,他们在随访期间新诊断为PD。参与者使用经过验证的食物频率问卷对重复的饮食评估做出反应,涵盖PD诊断前30年至诊断后10年以上。我们根据疾病诊断前后B族维生素累积平均摄入量的四分位数估计死亡的风险比(HR)和95%置信区间(CI)。我们还研究了pd特异性死亡率和其他暴露定义。结果在15年的随访中,我们记录了1005例死亡病例。PD患者在疾病诊断前较高的B族维生素累积平均摄入量与较低的死亡风险相关。多变量调整后的死亡率(95% CI),叶酸摄入量最高和最低四分位数的死亡率分别为0.78(0.62-0.99)、0.76(0.62-0.93)和0.86(0.69-1.09)。在限制补充来源摄入量的分析中,以及在考虑诊断前12年报告的摄入量的分析中,这些估计更为有力。PD诊断后摄入这些B族维生素与死亡风险无关。结论疾病诊断前摄入较多B族维生素,特别是叶酸和维生素B6,可降低PD患者的死亡风险。诊断后的摄入量似乎没有影响生存。
{"title":"Intake of Folate, Vitamin B6, and Vitamin B12 Before and After Disease Diagnosis and the Risk of Death in Individuals with Parkinson's Disease.","authors":"Xinyuan Zhang,Mario H Flores-Torres,Chadwick W Christine,Kjetil Bjornevik,Albert Y Hung,Michael A Schwarzschild,Alberto Ascherio","doi":"10.1002/mds.70178","DOIUrl":"https://doi.org/10.1002/mds.70178","url":null,"abstract":"Objective The aim of this study was to examine whether the intake of folate, vitamin B6, and vitamin B12 before and after disease diagnosis impacts the risk of death among individuals with Parkinson's disease (PD). The impact of folate, vitamin B6, and B12 intake on mortality in individuals with PD is unknown. Methods The study population comprised 1521 participants of two large prospective cohorts who were newly diagnosed with PD during follow-up. Participants responded to repeated dietary assessments using validated food frequency questionnaires, covering up to 30 years before to more than 10 years after PD diagnosis. We estimated the hazard ratio (HR) and 95% confidence interval (CI) of death according to quartiles of the cumulative average intake of B vitamins before and after disease diagnosis. We also examined PD-specific mortality and alternative exposure definitions. Results We documented 1005 deaths during 15 years of follow-up. A higher cumulative average intake of B vitamins before disease diagnosis was associated with a lower risk of death among patients with PD. The multivariable-adjusted HR (95% CI) of death comparing top to bottom quartiles of intakes was 0.78 (0.62-0.99) for folate, 0.76 (0.62-0.93) for B6, and 0.86 (0.69-1.09) for B12. These estimates were stronger in analyses restricting to intakes from supplemental sources and in those considering intakes reported up to 12 years before diagnosis. The intake of these B vitamins after PD diagnosis was not associated with the risk of death. Conclusions Higher intake of B vitamins before disease diagnosis, particularly folate and vitamin B6, may decrease the risk of death in individuals with PD. Postdiagnosis intake did not appear to impact survival.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"93 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Molecules to Populations: Is There a Role for Vitamin B6 in Parkinson's Disease? 从分子到人群:维生素B6在帕金森病中有作用吗?
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-12 DOI: 10.1002/mds.70189
Karlo J Lizarraga,Lu Wang,Michael P McDermott,Anthony E Lang
{"title":"From Molecules to Populations: Is There a Role for Vitamin B6 in Parkinson's Disease?","authors":"Karlo J Lizarraga,Lu Wang,Michael P McDermott,Anthony E Lang","doi":"10.1002/mds.70189","DOIUrl":"https://doi.org/10.1002/mds.70189","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"15 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Memoriam: Mark Hallett (1943–2025) 纪念:马克·哈雷特(1943-2025)
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-08 DOI: 10.1002/mds.70193
David J. Burn MD, Francisco E.C. Cardoso MD, PhD, Robert Chen MBBChir, MSc, Alberto J. Espay MD, MSc, Stanley Fahn MD, Susan H. Fox MBChB, PhD, Victor S.C. Fung MBBS, PhD, Christopher G. Goetz MD, Jennifer G. Goldman MD, MS, Joseph Jankovic MD, Beomseok Jeon MD, PhD, Anthony E. Lang MD, Andrew J. Lees MD, FMedSci, Marcelo Merello MD, PhD, Michael S. Okun MD, Werner Poewe MD, Carolyn M. Sue MBBS, PhD, Claudia Trenkwalder MD
{"title":"In Memoriam: Mark Hallett (1943–2025)","authors":"David J. Burn MD,&nbsp;Francisco E.C. Cardoso MD, PhD,&nbsp;Robert Chen MBBChir, MSc,&nbsp;Alberto J. Espay MD, MSc,&nbsp;Stanley Fahn MD,&nbsp;Susan H. Fox MBChB, PhD,&nbsp;Victor S.C. Fung MBBS, PhD,&nbsp;Christopher G. Goetz MD,&nbsp;Jennifer G. Goldman MD, MS,&nbsp;Joseph Jankovic MD,&nbsp;Beomseok Jeon MD, PhD,&nbsp;Anthony E. Lang MD,&nbsp;Andrew J. Lees MD, FMedSci,&nbsp;Marcelo Merello MD, PhD,&nbsp;Michael S. Okun MD,&nbsp;Werner Poewe MD,&nbsp;Carolyn M. Sue MBBS, PhD,&nbsp;Claudia Trenkwalder MD","doi":"10.1002/mds.70193","DOIUrl":"10.1002/mds.70193","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"41 1","pages":"19-26"},"PeriodicalIF":7.6,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145937527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Journal at Forty: A Proud Legacy and a Look to the Future 《四十周年期刊:骄傲的遗产与展望未来》。
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-07 DOI: 10.1002/mds.70188
A. Jon Stoessl CM, MD, FRCPC, FCAHS
{"title":"The Journal at Forty: A Proud Legacy and a Look to the Future","authors":"A. Jon Stoessl CM, MD, FRCPC, FCAHS","doi":"10.1002/mds.70188","DOIUrl":"10.1002/mds.70188","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"41 1","pages":"5-7"},"PeriodicalIF":7.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulation of Non‐Rhythmic Temporal Prediction by Subthalamic Nucleus Deep Brain Stimulation ( STN ‐ DBS) in Parkinson's Disease 丘脑下核深部脑刺激(STN - DBS)对帕金森病非节律性时间预测的调节
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-01-06 DOI: 10.1002/mds.70165
Rebecca Burke, Marleen J. Schoenfeld, Christian K.E. Moll, Alessandro Gulberti, Monika Pötter‐Nerger, Andreas K. Engel
Background Accurate temporal prediction, essential for adaptive motor behavior, relies on corticobasal ganglia circuits. In Parkinson's disease (PD), both motor and non‐motor functions are impaired. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) effectively alleviates motor symptoms, but its effects on non‐motor domains, like temporal prediction, remain less understood. Objective This study aimed to investigate how STN‐DBS influences temporal prediction performance and its underlying oscillatory dynamics in PD patients, with a particular focus on beta band power and delta band inter‐trial phase consistency (ITPC). Methods Thirteen PD patients (5 female, age: 64 ± 5.7 years; disease duration: 11.8 ± 1.8 years) with STN‐DBS performed a temporal prediction task with (DBS ON) and without (DBS OFF) stimulation, while 64‐channel EEG was recorded. Twenty age‐matched healthy controls completed the same task. Behavioral performance was assessed using psychometric functions and time–frequency analyses of electroencephalography (EEG) data on sensor and source‐level examined beta power and delta ITPC. Results PD patients showed impaired temporal prediction, but DBS improved performance to a level comparable with controls. EEG revealed reduced beta suppression in PD patients during DBS OFF, while beta suppression in DBS ON was comparable with controls. Both DBS OFF and ON exhibited reduced delta ITPC compared with controls. In DBS ON, source‐level delta ITPC was positively correlated with temporal prediction accuracy. Conclusions STN‐DBS improves temporal prediction performance in PD, likely through modulation of beta and delta oscillatory activity. However, while DBS effectively improves behavioral performance, oscillatory mechanisms underlying temporal prediction remain only partially restored. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
准确的时间预测对适应性运动行为至关重要,它依赖于皮质-基底神经节回路。在帕金森病(PD)中,运动和非运动功能都受损。深脑刺激(DBS)的丘脑下核(STN)有效地缓解运动症状,但其对非运动域的影响,如时间预测,仍然知之甚少。本研究旨在探讨STN - DBS如何影响PD患者的时间预测性能及其潜在的振荡动力学,特别关注β波段功率和δ波段试验间相位一致性(ITPC)。方法13例PD患者(女性5例,年龄64±5.7岁,病程11.8±1.8年)采用STN - DBS进行(DBS开)和(DBS关)刺激的时间预测任务,同时记录64通道脑电图。20名年龄匹配的健康对照组完成了同样的任务。行为表现采用心理测量功能和脑电图(EEG)数据的时频分析进行评估,这些数据来自传感器和源水平检测的β功率和δ ITPC。结果PD患者表现出时间预测受损,但DBS将其性能提高到与对照组相当的水平。脑电图显示PD患者在DBS OFF期间β抑制减少,而DBS ON期间β抑制与对照组相当。与对照组相比,DBS OFF和ON均表现出较低的δ ITPC。在DBS ON中,源水平δ ITPC与时间预测精度正相关。STN - DBS提高了PD的时间预测性能,可能是通过调节β和δ振荡活动。然而,虽然DBS有效地改善了行为表现,但时间预测的振荡机制仍然只是部分恢复。©2026作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
{"title":"Modulation of Non‐Rhythmic Temporal Prediction by Subthalamic Nucleus Deep Brain Stimulation ( STN ‐ DBS) in Parkinson's Disease","authors":"Rebecca Burke, Marleen J. Schoenfeld, Christian K.E. Moll, Alessandro Gulberti, Monika Pötter‐Nerger, Andreas K. Engel","doi":"10.1002/mds.70165","DOIUrl":"https://doi.org/10.1002/mds.70165","url":null,"abstract":"Background Accurate temporal prediction, essential for adaptive motor behavior, relies on corticobasal ganglia circuits. In Parkinson's disease (PD), both motor and non‐motor functions are impaired. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) effectively alleviates motor symptoms, but its effects on non‐motor domains, like temporal prediction, remain less understood. Objective This study aimed to investigate how STN‐DBS influences temporal prediction performance and its underlying oscillatory dynamics in PD patients, with a particular focus on beta band power and delta band inter‐trial phase consistency (ITPC). Methods Thirteen PD patients (5 female, age: 64 ± 5.7 years; disease duration: 11.8 ± 1.8 years) with STN‐DBS performed a temporal prediction task with (DBS ON) and without (DBS OFF) stimulation, while 64‐channel EEG was recorded. Twenty age‐matched healthy controls completed the same task. Behavioral performance was assessed using psychometric functions and time–frequency analyses of electroencephalography (EEG) data on sensor and source‐level examined beta power and delta ITPC. Results PD patients showed impaired temporal prediction, but DBS improved performance to a level comparable with controls. EEG revealed reduced beta suppression in PD patients during DBS OFF, while beta suppression in DBS ON was comparable with controls. Both DBS OFF and ON exhibited reduced delta ITPC compared with controls. In DBS ON, source‐level delta ITPC was positively correlated with temporal prediction accuracy. Conclusions STN‐DBS improves temporal prediction performance in PD, likely through modulation of beta and delta oscillatory activity. However, while DBS effectively improves behavioral performance, oscillatory mechanisms underlying temporal prediction remain only partially restored. © 2026 The Author(s). <jats:italic>Movement Disorders</jats:italic> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"40 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145902540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Moving Forward in Movement Disorders: The Need for Studies on Environmental Triggers” 回复:“运动障碍的发展:环境诱因研究的需要”
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-29 DOI: 10.1002/mds.70172
Lisa Harder‐Rauschenberger, Chi Wang Ip
{"title":"Reply to: “Moving Forward in Movement Disorders: The Need for Studies on Environmental Triggers”","authors":"Lisa Harder‐Rauschenberger, Chi Wang Ip","doi":"10.1002/mds.70172","DOIUrl":"https://doi.org/10.1002/mds.70172","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"28 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145847236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why the Second‐Hit Hypothesis Merits Center Stage in Peripherally Induced Movement Disorders? 为什么第二次撞击假说更有利于外周性运动障碍的中心阶段?
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-29 DOI: 10.1002/mds.70174
Abhishek Lenka, Joseph Jankovic
{"title":"Why the Second‐Hit Hypothesis Merits Center Stage in Peripherally Induced Movement Disorders?","authors":"Abhishek Lenka, Joseph Jankovic","doi":"10.1002/mds.70174","DOIUrl":"https://doi.org/10.1002/mds.70174","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"21 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145847282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Movement Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1